-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Imperial College London, University College London and Lilly have formed a coalition to change drug production in England.
, Lilly has pledged to invest more than 5 million pounds in research into more effective drug production, which it says could eventually lead to better and cheaper treatments for patients.
will be used to fund a virtual lab led by the Empire and will see researchers from two universities apply process systems engineering (PSE) methods to improve drug production.
process systems engineering is designed using computer-aided methods and models to control and optimize processes, chemicals and consumer goods industry processes in previous petrochemical methods.
"Applying PSE methods to the pharmaceutical industry has the potential to increase efficiency, reduce waste and address quality control issues throughout the manufacturing process," the partners noted.
will initially last six years, during which time researchers will focus on building more predictive models, designing more effective experiments, and improving the design of pharmaceutical systems.
"We are pleased to work with the UK's leading institutions to promote innovation in drug production," says Dr. Salvador García Muñoz, senior engineer consultant at Lilly's Small Molecule Design and Development Department. (This web article)